Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Hydralazine hydrochloride, Apresoline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 224Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Baxter’s Generics Hydralazine HCl Receives Approval in US
    Baxter’s Generics Hydralazine HCl Receives Approval in US

    17 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219797

    FDA
    17 Jul 2025
    Share Share
    Enforcement Report - Week of February 12, 2025
    Enforcement Report - Week of February 12, 2025

    12 Feb 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2025-94329.pdf

    FDA
    12 Feb 2025
    Share Share
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US

    21 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211010

    FDA
    21 Aug 2024
    Share Share
    Enforcement Report - Week of February 21, 2024
    Enforcement Report - Week of February 21, 2024

    21 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2024-40984.pdf

    FDA
    21 Feb 2024
    Share Share
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.

    17 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215988

    FDA
    17 Jan 2024
    Share Share